Clinical Trial Update: Primary Prevention of Allergic Disease in Early Child by Lactobacillus Reuteri [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether Lactobacillus reuteri can prevent allergic diseases in early childhood; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Diseases

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Linkoeping University | Conditions: Allergic Conditions | Phase 2 | Status: COMPLETED